Strategies used for to improve aqueous solubility of simvastatin: A systematic review;Estratégias utilizadas para melhoria da solubilidade da sinvastatina - Revisão sistemática

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 33, Issue 4, 2012, Pages 497-507

  de Vargas, Mara Rúbia Winter ^a   Raffin, Fernanda Nervo ^a   de Lima e Moura, Túlio Flávio Accioly ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Simvastatin; Solid dispersions; Solubility

Indexed keywords

DENDRIMER; LIPOSOME; SIMVASTATIN;

ARTICLE; CHEMICAL PROCEDURES; DISSOLUTION; DRUG SOLUBILITY; MICROEMULSION; MICROENCAPSULATION; NANOENCAPSULATION; SPRAY DRYING; SUPERCRITICAL FLUID EXTRACTION; SYSTEMATIC REVIEW;

EID: 84874669450     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Almeida H. Métodos para o incremento da solubilidade de substâncias activas pouco solúveis (BCS - Classe II). [Dissertação]. Lisboa: Faculdade de Farmácia, Universidade de Lisboa; 2009.
2. Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev. 2007;30; 59(7):546-67.
3. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20.
4. Ambike AA, Mahadik, KR, Paradkar A. Spray-Dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm Res. 2005;22(6):990-98.
5. Banakar UV. Pharmaceutical dissolution testing. New York: Marcel Dekker; 1992.
6. Colombo P, Bettini R, Santi P. Swellable matrices for controlled drug delivery:gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Tech Today. 2000;3(6):198-04.
7. Cunha-Filho MSS, Sá-Barreto LCL. Utilização de ciclodextrinas na formação de complexos de inclusão de interesse farmacêutico. Rev Ciênc Farm Básica Apl. 2007;28(1):1-9.
8. Csempesz F, Süle A, Puskas I. Induced surface activity of supramolecular cyclodextrin-statin complexes: relevance in drug delivery. Colloids Surf A. 2010;354(1-3):308-13.
9. Damasceno BPGL, Silva JA, Oliveira EE, Silveira WLL, Araújo IB, Oliveira AG, Egito EST. Microemulsão: um promissor carreador para moléculas insolúveis. Rev Ciênc Farm Básica Apl. 2011;32(1):9-18.
10. Ding Z, Hao A, Zhang P, Wang Z. Surface properties and solubility of simvastatin in the micelles of polyglycerol diisostearate ethoxylates. J Dispersion Sci Technol., 2007;28(4):495-00.
11. Dixit RP, Nagarsenker MS. Optimized microemulsions and solid microemulsion systems of simvastatin: characterization and in vivo evaluation. J Pharm Sci. 2010;99(12):4892-02.
12. Ford JL. The current status of solid dispersions. Pharm Acta Helv. 1986;61(3):69-88.
13. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II - Experimental evaluation of a eutectic mixture: Urea-acetaminophen system. J Pharm Sci. 1966;55(5):482-87.
14. Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum. 1965;4:117-212.
15. Jun SW, Kim M, Kim J, Park H, Lee S, Woo J, Hwang S. Preparation and characterization of simvastatin/hydroxypropyl-b-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 2007;66(3):413-21.
16. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274(1-2):65-7.
17. Kasin NA, et al. Molecular properties of WHO essential drugs and provisional Biopharmaceutical Classification. Mol Pharm. 2004;1(1):85-96.
18. Kulhari H, Poojaa D, Prajapatia SK, Chauhanb AS. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int J Pharm. 2011;405(1-2):203-09.
19. Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z, Wu W. Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles as Oral Drug Delivery Systems I. In Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug Simvastatin. AAPS PharmSciTech. 2009;10(3):960-6.
20. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions (Review Article). Eur J Pharm Biopharm. 2000 Jul;50(1):47-60.
21. Lopes CM, Lobo JM, Costa SP. Formas farmacêuticas de liberação modificada: polímeros hidrofílicos. Rev Bras Cienc Farm. 2005;41(2):143-54.
22. Magdassi S, Margulis-Goshen K. Formation of drug nanoparticles from microemulsions. Nanotech. 2010;3:308-11.
23. Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly-(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyllactate) in relation to indomethacin crystallization. Pharm Res. 1999;16:1722-28.
24. Margulis-Goshen K, Magdassi S. Formation of simvastatin nanoparticles from microemulsion. Nanomedicine. 2009;5(3):274-81.
25. Mourão LCS, Moura TFAL, Morais WA. Efeito da hidroxipropilmetilcelulose nas propriedades de complexação de beta-ciclodextrina com praziquantel. In: 1. Workshop Brasileiro de Tecnologia Farmacêutica e Inovação; 2011; Aracajú: Anais do 1o Worshop Brasileiro de Tecnologia Farmacêutica e Inovação, Universidade Federal de Sergipe; 2011.
26. Mourão LCS. Obtenção e caracterização de complexos de inclusão binários e ternários com praziquantel. [Dissertação]. Natal: Faculdade de Farmácia, Universidade Federal do Rio Grande do Norte; 2012.
27. Pandya P, Gattani S, Jain P, Khirwal L, Surana S. Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: In Vitro-In Vivo evaluation. AAPS PharmSciTech. 2008;9(4):1247-52.
28. Pandya VM, Patel JK, Patel DJ. Effect of different stabilizer on the formulation of simvastatin nanosuspension prepared by nanoprecipitation technique. Res J Pharm, Biol Chem Sci. 2010;910-17.
29. Patel R, Patel M. Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. J Disper Sci Technol. 2008;29:193-204.
30. Patil MS, Bavaskar KR, Girnar GA, Jain AS, Tekad AR Preparation and optimization of simvastatin nanoparticle for solubility enhancement and In Vivo study. Intern J Pharm Res Develop. 2011;2(12):219-26.
31. Rang HP, Dale MM, Ritter JM, Moore PK. Farmacologia. 5. ed. Rio de Janeiro: Editora Elsevier; 2004.
32. Rao M, Mandage Y, Thanki K, Bhise S. Dissolution improvement of simvastatin by surface solid dispersion technology. Dis Tech. 2010:27-34.
33. Sekiguchi K, Obi N. Studies on absorption of eutectic mixtures. I. A comparison of the behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chem Pharm Bull. 1961;9(11):866-72.
34. Silva TD. Desenvolvimento de métodos analíticos e de formulações para estatinas. [Dissertação]. Belo Horizonte: Faculdade de Farmácia, Universidade Federal de Minas Gerais; 2009.
35. Souto EB, Severino P, Santana MHA. Preparação de Nanopartículas Poliméricas a partir de Polímeros Pré-formados - Parte II (Artigo de Revisão). Polimeros. 2012;22(1):101-06.
36. Souza J, Freitas ZMF, Storpirtis S. Modelos in vitro para determinação da absorção de fármacos e previsão da relação dissolução/absorção. Rev Bras Ciênc Farm. 2007;43(4):515-27.
37. Storpirtis S, Gonçalves JE, Chiann C, Gai MN. Biofarmacotécnica. Rio de Janeiro: Editora Guanabara Koogan; 2009.
38. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflection on the field. Adv Drug Deliv Rev. 2005;57(15):2106-29.
39. Süle A, Csempesz F. Complexation of statins with ß-cyclodextrin in solutions of small molecular additives and macromolecular colloids. Prog Coll Pol Scis. 2008;135:93-100.
40. Takahashi AI. Obtenção e caracterização de complexos binários e ternários de sinvastatina e ciclodextrinas. [Dissertação]. São Paulo. Faculdade de Ciências Farmacêuticas, Universidade de São Paulo; 2009.
41. Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin - Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm. 2011;415(1-2):232-43.
42. Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, La Rotonda MI. Use of cyclodextrins as solubilizing agents for simvastatin: Effect of hydroxypropyl-ß-cyclodextrin on lactone/hydroxyacid aqueous equilibrium. Int J Pharm. 2011;404(1-2):49-56.
43. Vargas MRW, Lima Neto SA, Torres SM, Moura TFAL. Evaluation of phisicochemical properties of poorly water soluble drug (simvastatin) obtained by recristalization. In: 2. International Symposium of Pharmaceutical Sciences; 2011; Natal: Annals of International Symposium of Pharmaceutical Sciences, Universidade Federal do Rio Grande do Norte; 2011.
44. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007; 12(23-24):1068-75.
45. Vyas A, Saraf S, Saraf S. Encapsulation of cyclodextrin complexed simvastatin in chitosan nanocarriers: A novel technique for oral delivery. J Incl Phenom Macrocycl Chem. 2010;66:251-59.
46. Wen X, Liu Z, Zhu T. Mass spectrometry and molecular modeling studies on the inclusion complexes between α, ß-cyclodextrins and simvastatin. Chem Phys Lett. 2005;405(1-3):114-17.
47. Zhang Y, Zhang J, Jiang T, Wang S. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: Drug loading and release properties. Int J Pharm. 2011;410(1-2):118-24.